<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE html
     PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN"
     "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html dir="ltr" xml:lang="en" lang="en" xmlns="http://www.w3.org/1999/xhtml">
<!-- Added by HTTrack --><meta http-equiv="content-type" content="text/html;charset=utf-8" /><!-- /Added by HTTrack -->
<head>

<meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
<!-- 
	This website is powered by TYPO3 - inspiring people to share!
	TYPO3 is a free open source Content Management Framework initially created by Kasper Skaarhoj and licensed under GNU/GPL.
	TYPO3 is copyright 1998-2015 of Kasper Skaarhoj. Extensions are copyright of their respective owners.
	Information and contribution at http://typo3.org/
-->



<title>INHN: Hanfried Helmchen: The role of psychopharmacotherapy in the early development of social psychiatry in Germany</title>
<meta name="generator" content="TYPO3 4.5 CMS" />

<link rel="stylesheet" type="text/css" href="IMAGES/STYLESHEET_9B1E31873F2366.CSS?1645000983" media="all" />



<script src="IMAGES/JAVASCRIPT_93077BB238F3E1.JS?1645000982" type="text/javascript"></script>


<link href="IMAGES/LAYOUT_3COL_STANDARD.CSS" rel="stylesheet" type="text/css" /><!--[if lte IE 7]><link href="fileadmin/styles/patches/../01_layouts_basics/css/patches/patch_3col_standard.css" rel="stylesheet" type="text/css" /><![endif]-->
<meta name="DC.title" content="Hanfried Helmchen: The role of psychopharmacotherapy in the early development of social psychiatry in Germany" />
<meta name="description" content="INHN" />
<meta name="DC.Description" content="INHN" />
<meta name="keywords" content="International Network for the History of Neuropsychopharmacology" />
<meta name="DC.Subject" content="International Network for the History of Neuropsychopharmacology" />
<meta name="copyright" content="Copyright INHN 2012-14" />
<meta name="DC.Rights" content="Copyright INHN 2012-14" />
<meta http-equiv="content-language" content="en" />
<meta name="DC.Language" scheme="NISOZ39.50" content="en" />
<link rev="made" href="mailto:inhn@inhn.org" />
<meta http-equiv="reply-to" content="inhn@inhn.org" />
<meta name="author" content="Gregers Wegener" />
<meta name="DC.Creator" content="Gregers Wegener" />
<meta name="rating" content="General" />
<meta name="date" content="2018-04-03T00:34:06+00:00" />
<meta name="DC.date" content="2018-04-03T00:34:06+00:00" />
<meta name="robots" content="index,follow" />
<meta name="revisit-after" content="7" />
<link rel="start" href="INDEX681A.HTM?id=1" />
<link rel="up" href="INDEXAF9F.HTM?id=355" />
<link rel="next" href="INDEXE41A.HTM?id=2095" />
<link rel="prev" href="INDEX3202.HTM?id=1350" />
<link rel="canonical" href="INDEX2555.HTM?id=2447" />



</head>
<body id="pageUID-2447">


<div id="page_margins">
	<div id="page">
		<div id="header"><div class="tx-macinasearchbox-pi1">
		
<form action="https://inhn.org/index.php?id=5&amp;L=0" method="post" name="searchform" id="searchform">
<input name="tx_indexedsearch[sword]" type="text" value="Enter search word..." onclick="this.value=''" onblur="this.value='Enter search word...'" /><br />
<input type="hidden" name="tx_indexedsearch[_sections]" value="0" />
<input type="hidden" name="tx_indexedsearch[pointer]" value="0" />
<input type="hidden" name="tx_indexedsearch[ext]" value="0" />
<input type="hidden" name="tx_indexedsearch[lang]" value="0" />
</form>

	</div>
	<div id="topnav"><a class="skip" href="#navigation" title="Direkt zur Navigation springen">Zur Navigation springen</a><span class="hideme">.</span><a class="skip" href="#content" title="Direkt zum Content springen">Zum Content springen</a><span class="hideme">.</span><a href="INDEX3A9F.HTM?id=6" target="_self">Sitemap</a>&nbsp;&#124;&nbsp;<a href="INDEXD61C.HTM?id=5" target="_self">Search</a>&nbsp;&#124;&nbsp;<a href="INDEX65E4.HTM?id=kontakt" target="_self">Contact</a>&nbsp;&#124;&nbsp;<a href="INDEXB7B8.HTM?id=204" target="_self">About INHN</a></div><a href="INDEX2999.HTM?id=202"><img class="headImg1" src="IMAGES/COMPANY_LOGO.GIF" alt="" title="Home" width="598" height="100" /></a></div>
		<div id="nav"><a id="navigation" name="navigation"></a><div id="nav_main" class="hlist"><ul><li><a href="INDEX2999.HTM?id=202" target="_self"><span>Home</span></a></li><li><a href="INDEX7EFD.HTM?id=479" target="_self"><span>Dictionary</span></a></li><li><a href="INDEX3E5C.HTM?id=374" target="_self"><span>Drugs</span></a></li><li><a href="INDEXDBB1.HTM?id=565" target="_self"><span>Photos</span></a></li><li><a href="INDEXD919.HTM?id=342" target="_self"><span>Profiles</span></a></li><li id="current"><a href="INDEXAF9F.HTM?id=355" target="_self"><span>Controversies</span></a></li><li><a href="INDEXD122.HTM?id=641" target="_self"><span>Discoveries</span></a></li><li><a href="INDEX1F24.HTM?id=384" target="_self"><span>Books</span></a></li><li><a href="INDEX3958.HTM?id=467" target="_self"><span>Biographies</span></a></li><li><a href="INDEX677F.HTM?id=642" target="_self"><span>Perspectives</span></a></li><li><a href="INDEX8C00.HTM?id=343" target="_self"><span>Archives</span></a></li><li><a href="INDEX06CB.HTM?id=368" target="_self"><span>Ebooks</span></a></li><li><a href="INDEXA1F1.HTM?id=1755" target="_self"><span>Collated</span></a></li><li><a href="INDEXDF25.HTM?id=4128" target="_self"><span>Multilingual Project</span></a></li><li><a href="INDEXABE4.HTM?id=3884" target="_self"><span>INHN Publisher</span></a></li></ul></div></div>
		<div id="main">
			<div id="teaser" class="clearfix"><div class="rootline">You are here: <a href="INDEXAF9F.HTM?id=355" target="_self">Controversies</a>&nbsp;/&nbsp;Hanfried Helmchen: The role of psychopharmacotherapy in the early development of social psychiatry in Germany</div><div class="langMenu"><div class="tx-srlanguagemenu-pi1">
		
	</div>
	</div></div>
			<div id="col1">
				<div id="col1_content" class="clearfix">
					<ul id="submenu"><li id="title">Controversies</li><li><a href="INDEX01FF.HTM?id=3395" target="_self">Jay D. Amsterdam and Leemon B. McHenry: The Paroxetine 352 Bipolar Study Revisited: Deconstruction of Corporate and Academic Misconduct.</a><span class="hidden">.</span></li><li><a href="INDEXC230.HTM?id=486" target="_self">Thomas A. Ban: Conflict of interest in neuropsychopharmacology</a><span class="hidden">.</span></li><li><a href="INDEX2AF5.HTM?id=1342" target="_self">Thomas A. Ban: Development of our Vocabulary</a></li><li><a href="INDEX1BE7.HTM?id=3220" target="_self">Thomas A. Ban:  Education in Biological Psychiatry – Homage to Dr. Heinz E. Lehmann</a></li><li><a href="INDEXFB00.HTM?id=829" target="_self">Barry Blackwell: Adumbration; A history lesson</a><span class="hidden">.</span></li><li><a href="INDEX7196.HTM?id=3970" target="_self">Barry Blackwell: A Tale of Two Pioneers.</a></li><li><a href="INDEXD39F.HTM?id=1665" target="_self">Barry Blackwell: Corporate Corruption in the Psychopharmaceutical Industry</a><span class="hidden">.</span></li><li><a href="INDEXF833.HTM?id=1944" target="_self">Barry Blackwell: Corporate Corruption in the Psychopharmaceutical Industry. Revised</a><span class="hidden">.</span></li><li><a href="INDEX8B56.HTM?id=778" target="_self">Barry Blackwell: The anxiety enigma</a><span class="hidden">.</span></li><li><a href="INDEX8B7A.HTM?id=2096" target="_self">Barry Blackwell: The Baby and The Bath Water</a><span class="hidden">.</span></li><li><a href="INDEX07C2.HTM?id=622" target="_self">Barry Blackwell: The lithium controversy: A historical autopsy</a><span class="hidden">.</span></li><li><a href="INDEX12D3.HTM?id=1369" target="_self">Pierre Baumann and Francois Ferrero: An official inqury of the clinical research activities (1946-1972) of Roland Kuhn (1912-2005)</a><span class="hidden">.</span></li><li><a href="INDEXA7C8.HTM?id=2954" target="_self">John Court: A note on the history of Anorexia Nervosa</a></li><li><a href="INDEX32F0.HTM?id=421" target="_self">Paul Devenyi: Addictions are not treatable diseases</a><span class="hidden">.</span></li><li><a href="INDEXE29D.HTM?id=477" target="_self">Paul Devenyi: Pharmacotherapy of addictions</a></li><li><a href="INDEXC591.HTM?id=3315" target="_self">Camille Drach Hojaij: Stein and Empathic Fulfilment.</a><span class="hidden">.</span></li><li><a href="INDEX3CB5.HTM?id=2526" target="_self">François Ferrero: Inquiry of the Geneva 1980s’ Psychiatry Crisis</a><span class="hidden">.</span></li><li><a href="INDEXC947.HTM?id=3727" target="_self">Max Fink: Reconceptualization of Catatonia.</a><span class="hidden">.</span></li><li><a href="INDEX3D6D.HTM?id=2322" target="_self">Ernst J. Franzek: From the dichotomy to a three-part grouping of endogenous psychoses</a><span class="hidden">.</span></li><li><a href="INDEX031F.HTM?id=3472" target="_self">Samuel Gershon: Brintellix  -  votioxetine</a></li><li><a href="INDEXCD60.HTM?id=3191" target="_self">Samuel Gershon: Device for naltrexone delivery</a></li><li><a href="INDEX8E42.HTM?id=3064" target="_self">Samuel Gershon: Ketamine, the “new” breakthrough in the treatment of depression</a><span class="hidden">.</span></li><li><a href="INDEX1823.HTM?id=2488" target="_self">Samuel Gershon: Lithium history</a><span class="hidden">.</span></li><li><a href="INDEX5D83.HTM?id=3646" target="_self">Samuel Gershon: The emergence of “new” drugs in recent years.</a></li><li><a href="INDEXFA6F.HTM?id=3375" target="_self">Samuel Gershon: The Tacrine paradigm.</a><span class="hidden">.</span></li><li><a href="INDEXF3E3.HTM?id=670" target="_self">Samuel Gershon: The trazodone cntrovery and its potential fatal consequences</a></li><li><a href="INDEX4A93.HTM?id=2894" target="_self">Ken Gillman: Medical science publishing: A slow-motion train wreck</a><span class="hidden">.</span></li><li><a href="INDEXDBE8.HTM?id=3720" target="_self">David Healy: Do Randomized Controlled Trials Add to or Subtract from Clinical Knowledge?</a><span class="hidden">.</span></li><li><a href="INDEX3202.HTM?id=1350" target="_self">David Healy: The shipwreck of the singular</a><span class="hidden">.</span></li><li><strong>Hanfried Helmchen: The role of psychopharmacotherapy in the early development of social psychiatry in Germany</strong><ul><li><a href="INDEX8412.HTM?id=2710" target="_self">Shridhar Sharma’s comment</a></li><li><a href="INDEX162F.HTM?id=2884" target="_self">Hanfried Helmchen’s reply (comment) on Shridhar Sharma’s comment</a></li><li><a href="INDEXFFDB.HTM?id=3075" target="_self">Shridhar Sharma’s response to Hanfried Helmchen’s reply</a></li><li><a href="INDEXDFD5.HTM?id=2997" target="_self">Edward Shorter’s comments</a></li><li><a href="INDEX39B8.HTM?id=3183" target="_self">Hanfried Helmchen‘s reply to Edward Shorter’s comments</a></li><li><a href="INDEX9847.HTM?id=3364" target="_self">Hector Warnes' comment on Hanfried Helmchen's reply to Edward Shorter's comment</a></li></ul></li><li><a href="INDEXE41A.HTM?id=2095" target="_self">Carlos R. Hojaij: A Psychopathological Marker For Biological Psychiatry:  The Point of No Return and the “Something New&quot; *</a></li><li><a href="INDEX4C30.HTM?id=1823" target="_self">Carlos R. Hojaij: “DSM-5: The Future of Psychiatric Diagnosis” or Continuing the Psychiatry DiSMantlement</a><span class="hidden">.</span></li><li><a href="INDEX14F7.HTM?id=2103" target="_self">Carlos R. Hojaij: Psychiatry and Medicine</a></li><li><a href="INDEX711C.HTM?id=2118" target="_self">Carlos R. Hojaij: Towards a Psychiatric Biology</a></li><li><a href="INDEX61B8.HTM?id=3147" target="_self">David Janowsky: Cholinergic muscarinic mechanisms in depression and mania</a><span class="hidden">.</span></li><li><a href="INDEXC12C.HTM?id=3956" target="_self">Daniel Kanofsky and Mary E. Woesner: A Fresh Air Approach to COVID-19.</a><span class="hidden">.</span></li><li><a href="INDEX0B8F.HTM?id=530" target="_self">Martin M. Katz: Component-Specific vs. Diagnosis-Specific Clinical Trial in Depression</a><span class="hidden">.</span></li><li><a href="INDEXBDA3.HTM?id=594" target="_self">Martin M. Katz: Multivantaged vs. conventional assessment method</a><span class="hidden">.</span></li><li><a href="INDEX46C5.HTM?id=496" target="_self">Martin M. Katz: Onset of clinical action of antidepressants</a><span class="hidden">.</span></li><li><a href="INDEX94E9.HTM?id=1147" target="_self">Martin  M. Katz: The need and rationale for shortenng the clinical trial for antidepressants</a></li><li><a href="INDEXB724.HTM?id=2329" target="_self">Donald F. Klein, Max Fink, Edward Shorter and Thomas A. Ban: Comment exchange on Flagrant Catatonic Behavior.</a><span class="hidden">.</span></li><li><a href="INDEXA16A.HTM?id=1625" target="_self">Joseph Knoll: Controversies on selegiline/(-)-deprenyl’s  pharmacological spectrum after more than 50 years of its development</a></li><li><a href="INDEX98B4.HTM?id=2771" target="_self">Magda Malewska-Kasprzak, Agnieszka Permoda-Osip, Janusz Rybakowski:Disturbances of the purinergic system in affective disorders and schizophrenia</a><span class="hidden">.</span></li><li><a href="INDEXBB29.HTM?id=4134" target="_self">Trudo Lemmens. “Medical Assistance in Dying” (Euthanasia and Assisted Suicide) in Canada: A Case Raises Questions About Its Use in Patients with Disability and Mental Illness.</a><span class="hidden">.</span></li><li><a href="INDEXEBA9.HTM?id=3891" target="_self">Amy S. F. Lutz: The Rise and Fall of the Dexamethasone Suppression Test: Stability, Consensus, Closure.</a><span class="hidden">.</span></li><li><a href="INDEX41D4.HTM?id=3252" target="_self">Gin S. Malhi: A critical analysis of concepts in psychiatry</a><span class="hidden">.</span></li><li><a href="INDEXD25B.HTM?id=2701" target="_self">Antonio E. Nardi, Richard Balon, Guy Chouinard, Fiammetta Cosci, Steven Dubovsky, Giovanni A. Fava, Rafael C. Freire, David J. Greenblatt, John H. Krystal, Karl Rickels, Thomas Roth, Carl Salzman, Richard I. Shader, Edward K. Silberman, Nicoletta Sonino,</a><span class="hidden">.</span></li><li><a href="INDEX4CFC.HTM?id=2972" target="_self">János Radó: Renal Toxicity of Lithium in Historical Perspective with Special Reference To Nephrogenic Diabetes Insipidus and its Treatment</a><span class="hidden">.</span></li><li><a href="INDEXD26F.HTM?id=3140" target="_self">Janos Radó: Desmopressin may counteract polyuria in lithium-induced nephrogenic diabetes insipidus. Review of the literature</a><span class="hidden">.</span></li><li><a href="INDEX13F5.HTM?id=1248" target="_self">Shridhar Sharma: Insulin coma treatment: Facts and controversies</a><span class="hidden">.</span></li><li><a href="INDEX5461.HTM?id=390" target="_self">Edward Shorter: The Q-T interval and the Mellaril story - a cautionary tale</a><span class="hidden">.</span></li><li><a href="INDEX70B9.HTM?id=2755" target="_self">Leonardo Tondo: Brief History of Suicide in Western Cultures</a><span class="hidden">.</span></li><li><a href="INDEX7938.HTM?id=2000" target="_self">Hector Warnes: The gut-brain axis</a><span class="hidden">.</span></li><li><a href="INDEXEABE.HTM?id=3450" target="_self">Hector Warnes: Pyridoxine in the treatment of lithium-induced tremor.</a><span class="hidden">.</span></li></ul>
					
					<div class="textBelowMenu"><!--TYPO3SEARCH_begin--><!--TYPO3SEARCH_end--></div>
				</div>
			</div>
			<div id="col2">
				<div id="col2_content" class="clearfix"><!--TYPO3SEARCH_begin--><!--TYPO3SEARCH_end--></div>
			</div>
			<div id="col3">
			  <a id="content" name="content"></a>
				<div id="col3_content" class="clearfix">
					<div class="floatbox"><!--TYPO3SEARCH_begin--><div id="c4270" class="csc-default"><h1><b>Hanfried Helmchen: The role of psychopharmacotherapy in the early development of social psychiatry in Germany<sup>1</sup></b></h1>
<p>&nbsp;</p>
<p>Not the least as a reaction to the collectivistic ideology and the biological reductionism of National Socialism, humanitarian aspects such as the personal history and social context of the individual gained influence on psychiatric thinking after the war in Germany. This development became manifest in anthropological psychiatry. It came into being with the “understanding anthropology” around Jürg Zutt (1893-1980), professor of psychiatry and head of the Department of Psychiatry at the Frankfurt University (1950-1967), as well as with Walter v. Baeyer (1904-1987), professor of psychiatry and head of the Department of Psychiatry at Heidelberg University (1955-1972) and later on vice president of the World Psychiatric Association (WPA) (1966-1971), who already in 1955 directed with his “concept of encounter” (<i>Begriff der Begegnung</i>) the view on the essential therapeutic factor of bringing about a relationship with the ill individual. &nbsp;&nbsp;&nbsp;</p>
<p>As early as in 1947 his experience as chief physician of the psychiatric department in the large general hospital at Nuremberg caused him to speak about “social psychiatry” (Kretz 2004); this concept was then elaborated in the 1960s by his pupils <a name="_Hlk508286811">Heinz </a>Häfner and Karl-Peter Kisker (Häfner 1965)<b><sup>2</sup></b> and was institutionalized by the “<i>Psychiatry-Enquéte</i> of the German Parliament (<i>Deutscher Bundestag</i>) for the reform of psychiatry (1971-1975)” through the reorganization of psychiatric care. The chairman of the Enquéte-Commission was Caspar Kulenkampff, who had established a Department of Social Psychiatry at the Frankfurt University Hospital in 1959. These ideas developed further in the late 1950s and 1960s particularly in southwestern Germany via the psychotherapeutically engaged professor <a name="_Hlk508280544">Hanns Ruffin </a>(1902-1979) in Freiburg (1951-1967) and asylum-experienced<b><sup>3</sup></b> professor Walter Schulte (1910-1972) in Tübingen (1960-1972), as well as through a network of young psychiatrists (the so-called <i>Rhein-Main-Kreis</i>) from these university departments (Söhner, Becker and Fangerau 2017). Finally, the “brutal reality” of the insane asylums neglected and left in miserable condition by the National Socialist crimes and the dire need of the postwar years (Kersting and Schmuhl 2004) motivated young psychiatrists to a movement for reform that resulted in the “Mannheim circle” and, in 1971, the German Society of Social Psychiatry. Thus, the impression is justified that the inhumane conditions of insane asylums and a new anthropologically reasoned view of the mentally ill resulted in a social psychiatric reform of German psychiatry (Thoma 2012).</p>
<p>However, the question has been scarcely elaborated systematically of how the almost simultaneously developing psychopharmacotherapy<b><sup>4</sup></b> influenced this development. Initially it was looked at as “one of the most important requirements of the acceleration of social psychiatric efforts” <a name="_Hlk508262316">(</a>Dörner and Plog 1999), but with diverse relevance and justifications in different contexts (Dörner and Plog 1999; Lauter 1968; Hippius 1968), all the way to only small, questionable or no significance at all (Häfner 1968; Odegard 1964; Smith, Bower and Wignal 1965; Niemann 2008). Therefore, attention will be drawn to interactions between the biological and social dimension from my own knowledge of historical data from Berlin.</p>
<p>Reports of the impressive effects of chlorpromazine on acute psychotic conditions, which were published in 1952 by Jean Delay (1907-1987), professor of psychiatry in Paris, and his collaborators Pierre Deniker et al., immediately excited strong interest in some assistants of German psychiatric hospitals, e.g., in Heidelberg (Janzarik 1954) and Munich (Kolle and Mikorey 1953), and also in the Psychiatric Department of the Free University of Berlin.</p>
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; As early as 1954, a first publication (“hibernation therapy of acute psychoses”) from this department was published (Hiob 1954), followed in 1955 by a comprehensive report “comparing the psychopathology of the shock and phenothiazine effects” (Hartmann, Hiob and Hippius 1955), as well as publications on side-effects of the phenothiazine therapy (Hiob and Hippius 1955). In 1988 Hanns Hippius<b><sup>5</sup> </b>described retrospectively the related remarkable improvement of psychiatric treatment “from the impact on psychopathological symptoms through the humanization of the ward atmosphere to the possibilities of outpatient and prophylactic treatment against relapses instead of long-term institutionalization” (Hippius 1988). </p>
<p>The pharmacotherapeutically induced quick and augmented accessibility of the patient opened the view more than to date toward his living conditions, his familiar environment and his social situation (Freyhan 1966). Soon the question arose whether a long-term drug treatment might prevent relapses and recurrences and could support social rehabilitation. “Today the difficulties of the treatment of psychoses are increasingly shifting from the treatment of psychotic symptoms to the re-entrance of the remitted person into his profession and family… As a consequence, problems from the social sphere of influence frequently become more meaningful than the purely medical ones. If these factors are overlooked or neglected, the risk exists that the boost might trickle away that the psychiatric therapy received by the introduction of the psychotropic drugs. The impulses of pharmacopsychiatry must be taken up by social psychiatry” <a name="_Hlk508265262">(Enss and Hippius 1964)</a>. Thereby the perspective of a rehabilitatively oriented long-term outpatient treatment arose.</p>
<p>These experiences with long-term, drug-treated patients developed toward the demand “to reintegrate the remitted patient without disturbance into his social milieu …to meet the requirements of a gradual social and psychiatric rehabilitation.” Consequently Hanns Hippius, together with some colleagues, particularly Hildegard Enss, tried to implement these demands. Thus, he contacted Dr. Dietrich Blos, the president of the Berlin Red Cross Association, who in 1956 established the Phoenix House (<i>Haus Phönix</i>) for admission of discharged schizophrenic patients, as the first half-way house in the Federal Republic and West-Berlin – supported by the Berlin lottery (Enss and Hippius 1964). </p>
<p>Before then the existing (somatic shock-) treatments could improve the prognosis of acute schizophrenic episodes but not the long-term prognosis. &quot;Thus, the search for a therapeutic method the application of which would be effective for a long or even permanent duration continued to remain one of the urgent tasks of psychiatric therapy. A long-term applicable mode of treatment is most likely to raise the hope of improving the long-term prognosis of schizophrenics” (Enss, Hartmann, Hippius et al. 1960). </p>
<p>Therefore, “…on July 1, 1957, the first catamnesis began with 241 schizophrenic patients; after completion of their inpatient first treatment they were transferred systematically from two closed wards into a long-term treatment with perazine for an average of 6-12 weeks’ duration” (Enss, Hartmann, Hippius et al. 1960). It was to be tested whether the ambulatory drug treatment with perazine (Enss, Hartmann, Hippius H et al. 1958), a drug with only few side effects, would reduce significantly the number of relapses after five years (<a name="_Hlk508281321">Helmchen, Hippius and Tiling 1967</a>). <sup>6 &nbsp;</sup>It became apparent that the adherence of a patient to the conduct of a long-term treatment was determined not only by individual and medical staff, but also by social factors” <a name="_Hlk508266201">(Richter 1961)</a>. Not only the obtained grade of remission but “also decisive for the reliability in the long-term treatment are the living condition, the atmosphere at home as well as the attitude of related persons with regard to the illness and therapy of the patient” &nbsp;(Richter 1961). Therefore, the care of patients was fostered by a gradual process of rehabilitation and institutionalized by a social department in 1960.</p>
<p>The intensive medical and caring support of the long-term drug treatment led to different modifications of interventions in order to prevent or attenuate impending recurrences, not only by adaptations of the dosage executed sometimes by experienced patients themselves, but by overnight admissions for adjustment of the medication and for talks with the psychiatrist. Those patients not yet fit for work but almost for discharge stayed only during the day in the hospital but with their families during the night. For institutionalization of these interventions, in 1962 the Phoenix House was extended to a “half-way house with a day and night hospital” (<a name="_Hlk508281716">Hippius </a>2017).<b><sup>7</sup></b></p>
<p>His own experiences and increasing discussions on necessary changes in the structures of psychiatric care<b><sup>8</sup></b> motivated Hanns Hippius to call for a department of psychiatric epidemiology and social psychiatry (in his negotiations for refusing a call to the university in Hamburg in 1968); the faculty and academic senate of the Free University of Berlin decided in favor of this in 1970 (Hippius 2006) and established it in 1972 with Gregor <a name="_Hlk508286304">Bosch </a>as head; Bosch had gained his social psychiatric expertise, among other experience, with the setup of the social psychiatric institution initiated by Caspar Kulenkampff in Frankfurt.</p>
<p><b>Summary</b></p>
<p>Early experiences are reported that psychopharmacotherapy, particularly the relapse-preventing long-term medication, has led to an increased recognition of social determinants of the course of illness, especially in schizophrenic patients. As a result, social psychiatric institutions developed, e.g., in Berlin from <a name="_Hlk508281613">half-way house </a>(<i>Übergangsheim</i>) “Phoenix” in 1956; through a catamnesis for long-term outpatient treatment of schizophrenic patients in 1957; a social service in 1960; a day and night hospital in 1962; all the way to a university department of social psychiatry in 1972 with a rich spectrum of institutions for a gradual rehabilitation of mentally ill patients.</p>
<p>In comparison with well-known humanistic sources of German psychiatric reform we discuss here some less well-known sources based on psychopharmacotherapeutic experiences that need further historical elaboration. Some questions are: 1. how has psychiatric pharmacotherapy influenced the development of social psychiatry in Germany?; 2. has the pioneering spirit of the 1950s, initiated by the new treatments with psychotropic drugs, fostered the development of social psychiatry, although in Germany this development was delayed <b><sup>9</sup></b> (Hippius 1968) in comparison with England, France, and Canada until the end of the 1960s; and 3. has (possibly related to the post-war international isolation of German psychiatry) the retardation of the development of social psychiatry in Germany been overcome, not the least by the new scientific development of psychopharmacology that encouraged international contacts and thus increased knowledge among German psychiatrists of social psychiatric institutions in other countries? In any case, the possible influence of psychopharmacotherapy should not be mis­sed in an overall view of the development of social psychiatry in Germany.</p>
<p>&nbsp;</p>
<p><b>Author’s Notes:</b> </p>
<p>1 &nbsp;&nbsp;&nbsp; The title of this essay is based on: Helmchen H (2017) <i>Zur Rolle der Psychopharmakotherapie in der Entwicklung der Sozialpsychiatrie. </i><i>Nervenarzt</i> 89 (1) 88-91 DOI:10.1007/s00115-017-0464-2.</p>
<p>2&nbsp;&nbsp; Heinz Häfner’s 1965 memorandum initiated a development that resulted in the Central Institute of Mental Health in Mannheim, which opened in 1975.</p>
<p>3&nbsp; &nbsp;&nbsp;&nbsp;Walter Schulte was the leading physician from 1947-1954 in the German psychiatric asylum Bethel (1954-1960) Bethel, 1954-1960 of the psychiatric asylum Gütersloh.</p>
<p>4&nbsp; &nbsp;&nbsp;Psychiatric drug therapy was not only a new basis for the treatment of patients, but also became a tool for research into biological mechanisms of mental disorders and led to the term “biological psychiatry” (Helmchen and Hippius 1975).</p>
<p>5&nbsp;&nbsp;&nbsp;&nbsp; Hanns Hippius, an assistant at the Berlin hospital since 1952, was interested in psychopharmacology; in 1955 he participated in the first Colloque International de Chlorpromazine in Paris; in 1957 he was invited by the Basel pharmacologist Ernst Rothlin as a representative of the young generation of German scientists to the founding of the Collegium Internationale Neuropsychopharmacologicum (CINP) in Zürich; and in 1974 he was elected CINP president.</p>
<p>6 &nbsp;&nbsp;&nbsp;Helmchen, Hippius and Tiling in 1967 reported that after three years, 59% of the drug-treated patients remained free of recurrences, but only 20% of the patients were without long-term treatment.</p>
<p>7&nbsp;&nbsp;&nbsp;&nbsp; In his personal correspondence of August 27, 2017, Hippius stated that he reported to Caspar Kulenkampff his impressions from his visits of social psychiatric institutions in Canada; after this Kulenkampff visited Hippius in Berlin, visited the social psychiatric institutions around the half-way house “Phoenix” – and published about the night hospital that he had implemented in Frankfurt (Kulenkampff 1961).</p>
<p>8&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;Hippius was also influenced by a “social psychiatric working group Berlin” (SPAK), which was founded in 1970 mainly by assistants of the university psychiatry department and presented in 1972 a “pink paper” (Lehmkuhl 2008).</p>
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Since 1967 social psychiatric services based on 1920 models of reform were established at the administrative offices of the Berlin burroughs by the decisive initiative of Dr. Ruth Mattheis from the Berlin Senate (Lehmkuhl 2007). Previously, Dr. Barbara v. <a name="_Hlk508283323">Renthe-Fink </a>from the Berlin Senate commented: “really successful was only a long-term planned development of social psychiatric services. Long before the Enquète of the Federal Government for the psychiatric care in the Federal Republic of Germany this model of decentralized psychiatry was established” (Renthe-Fink 1982).</p>
<p>9&nbsp;&nbsp;&nbsp; As printed in “Psychiatry - Proceedings of the IV World Congress of Psychiatry, Madrid 1966,” Hippius wrote: “Today (1966) in Germany social psychiatric concepts are only very reluctantly gaining acceptance. Thus, in the Federal Republic of Germany and West-Berlin up to now only three of the 21 psychiatric university hospitals offer some years of experience with a social psychiatric aftercare unit with day- and night services. Prerequisite and inducement for the development of such an institution in Berlin were the encouraging successes of the long-term drug treatment.”</p>
<p><b>References</b>:</p>
<p>&nbsp;</p>
<p>Dörner K, Plog U. <i>Anfänge der Sozialpsychiatrie. Sozialpsychiatrische Texte 2</i>. Psychiatrie-Verlag, Bonn, 1999; p. 20. </p>
<p>&nbsp;</p>
<p>Enss H, Hippius H. <i>Sozialpsychiatrische Aspekte der modernen Psychosentherapie</i>. Deutsches Med J 1964; 15, pp. 529-531. </p>
<p>&nbsp;</p>
<p>Enss H, Hartmann K, Hippius H et al. <i>Zur ambulanten medikamentösen Dauertherapie remittierter Schizophrener. 1.Mitteilung: Zielsetzung und methodische Grundlagen.</i> Med Welt 1960; 37, pp.1911-1918. </p>
<p>&nbsp;</p>
<p>Enss H, Hartmann K, Hippius H et al. <i>Klinische Erfahrungen mit einem neuen Piperazin-Derivat des Phenothiazins in der Neuro-Psychiatrie</i>. Arch Psychiat Nervenkr 1958 197; 534-550.</p>
<p>&nbsp;</p>
<p>Freyhan F. The Age of Community Psychiatry. In: López Ibor J (ed). Psychiatry - Proceedings of the IV World Congress of Psychiatry, Madrid 1966, Vol. Part 1. Amsterdam/Madrid: Excerpta Medica; 1968; pp. 351-3. </p>
<p>&nbsp;</p>
<p>Häfner H. <i>Dringliche Reformen in der psychiatrischen Krankenversorgung der Bundesrepublik.</i> Helfen und Heilen. 1965; 4: 1-8. </p>
<p>&nbsp;</p>
<p>Häfner H. <i>Über die Rehabilitation</i>. In: López Ibor JJ (ed). Psychiatry - Proceedings of the IV World Congress of Psychiatry, Madrid 1966, Vol Part 1. Amsterdam: Excerpta Medica; 1968, p. 541.</p>
<p>&nbsp;</p>
<p>Hartmann K, Hiob J, Hippius H. [Comparative psychopathology of the effects of shock and phenothiazine therapy]. Fortschr Neurol Psychiatr Grenzgeb. 1955 Aug;23(8):354-66.</p>
<p>&nbsp;</p>
<p>Helmchen H, Hippius H. <i>Entwicklungstendenzen biologischer Psychiatrie</i>. Stuttgart: Thieme; 1975.</p>
<p>&nbsp;</p>
<p>Helmchen H, Hippius H, Tiling P. <i>Die Zusammenarbeit zwischen Klinik und Praxis bei der langfristigen medikamentösen Behandlung von Psychose-Kranken</i>. Internist 1967; 8: 328-31, p. 329.</p>
<p>&nbsp;</p>
<p>Hippius H. <i>Nutzen und Gefahren der Psychopharmaka für die Entwicklung der Community Psychiatry</i>. <a name="_Hlk508262919">In: López Ibor JJ (ed). </a><a name="_Hlk508283787">Psychiatry - Proceedings of the IV World Congress of Psychiatry, Madrid 1966,</a> Vol Part 1. Amsterdam: Excerpta Medica; 1968; pp 391-5, p. 392/1.</p>
<p>&nbsp;</p>
<p>Hippius H. Hippius Hanns. In: Ban TA &amp; Hippius H (eds). Psychopharmacology in Perspective. Berlin/Heidelberg/New York: Springer; 1988; pp. 55-8. </p>
<p>&nbsp;</p>
<p>Hippius H. Personal communication, August 27, 2017.</p>
<p>&nbsp;</p>
<p>Hippius H. Personal communication, March 2, 2006.</p>
<p>&nbsp;</p>
<p>Kersting F-W, Schmuhl H-W. <i>Quellen zur Geschichte der Anstaltspsychiatrie in Westfalen, Bd. 2: 1914-1955. Forschungen zur Regionalgeschichte</i>. Vol. 48. Paderborn: Verlag Ferdinand Schöningh; 2004. &nbsp;</p>
<p>&nbsp;</p>
<p><a name="_Hlk508260195">Kretz </a>H. <i>Psychiatrie im Umbruch</i>. Deutsches Ärzteblatt. 2004; 101: 559-60. </p>
<p>&nbsp;</p>
<p>Lauter H. <i>Der psychisch Gestörte in der Gesellschaft. Epidemiologische Daten, Fakten, Vorurteile und Einstellungen</i>. In: Anders E &amp; Kulenkampff C (eds). <i>Der Verrückte in der Gesellschaft Aufgaben und Chancen der Psychiatrie</i>, Stuttgart: Radius-Verlag; 1968; pp. 9-25, p. 24. </p>
<p>&nbsp;</p>
<p>Lehmkuhl D. <i>Reformpsychiatrie in Zeiten antiautoritärer und antipsychiatrischer Bewegungen - ein Zeitzeugenbericht.</i> In: Helmchen H (ed). <i>Psychiater und Zeitgeist Zur Geschichte der Psychiatrie in Berlin</i>. Pabst Science Publishers, Lengerich. 2008; pp. 333-348, p. 340.</p>
<p>Lehmkuhl D. <i>Sozialpsychiatrische Dienste in Berlin - Aufgaben und aktuelle Probleme</i>. Berliner Ärzte 2007; 44, &lt;s&gt;2007&lt;/s&gt;;28-30.</p>
<p>Niemann PJ. <i>Psychiatrische Transformationsprozesse und die Enthospitalisierung im Kontext der Einführung der Neuroleptika in der Bundesrepublik Deutschland</i>. Institut für Geschichte und Ethik der Medizin des Zentrums für Psychosoziale Medizin Vol. Medizinische Fakultät der Universität Hamburg, Hamburg, 2008.</p>
<p>&nbsp;</p>
<p>Odegard O. Pattern of discharge from Norwegian psychiatric hospitals before and after the in-troduction of the psychotropic drugs. Am J Psychiatry. 1964; 120, 772-8. </p>
<p>&nbsp;</p>
<p>Renthe-Fink B. <i>So alt wie das Jahrhundert. Lebensbericht einer Berliner Ärztin.</i> RG Fischer, Frankfurt am Main.,1982; p.88.</p>
<p>&nbsp;</p>
<p>Richter H-E. <i>Soziale Aspekte der ambulanten Dauertherapie mit Psychopharmaka</i>. Deutch Med J 1961; 12: 532-3.</p>
<p>&nbsp;</p>
<p>Smith TC, Bower WH, Wignal CM.&nbsp; Influence of Policy and Drugs on Colorado State Hospital Population. Arch Gen Psychiatry, 1965;12, 352-62.</p>
<p>&nbsp;</p>
<p><a name="_Hlk508261060">Söhner F, Becker T, Fangerau </a>H. <i>Die Rolle der anthropologischen Psychiatrie in der Vorbereitungs-zeit der Psychiatrie-Enquete und Psychiatriereform in der Bundesrepublik Deutschland</i>. Psychiat Prax, 2017; 44; 252-7.</p>
<p>&nbsp;</p>
<p>Thoma S. <i>Phänomenologisch-anthropologische Sozialpsychiatrie – Wegmarken für eine theoretische Wiederbelebung</i>. Psychiat Prax 2012; 39, 407-9.</p>
<p>&nbsp;</p>
<p>April 5, 2018</p></div><!--TYPO3SEARCH_end--></div>
				</div>
				<div id="ie_clearing">&nbsp;</div>
			</div>
		</div>
		<div id="footer">&copy; INHN 2012-2022 ::: INHN Central Office  · Av. Sagrada Familia Esq Nazaret · Córdoba, Córdoba X5000 · Argentina  ::: email: inhn@inhn.org</div>
	</div>
</div>





<script src="IMAGES/URCHIN.JS" type="text/javascript">
</script>
<script type="text/javascript">
_uacct = "UA-39727086-1";
urchinTracker();
</script>
</body>
</html>